Select a community
All Communities
Home > Community Treatment Reports > IVIg Intravenous Immuno Globulin Treatment Report
What is IVIg Intravenous Immuno Globulin?

Intravenous Immune Globulin (IVIG) is a human blood product consisting of antibodies which is used to treat immune disorders including myaesthenia gravis and multifocial motor neuropathy. It is sometimes trialed on ALS patients during the diagnostic process to rule out other illnesses. Read more...Click to read more below

Side Effects

Side effects as an overall problem

Severe
1 4%
Moderate
6 26%
Mild
8 35%
None
8 35%

Most commonly reported side effects

Headaches
11 48%
Weight gain
4 17%
Hives
2 9%
Edema -swollen feet, ankles, hands
2 9%
mild, short lived headache
2 9%
tired
2 9%
  • Mild
  • Moderate
  • Severe

Dosages

Top 10 dosages based on patients currently taking IVIg Intravenous Immuno Globulin. See all 42 dosages

  as needed 0.5 g monthly 1 g monthly 1.5 g monthly 5 g monthly 6 g monthly 10 g monthly 12 g monthly 15 mg monthly 25 g monthly 25 mg monthly 30 g monthly 30 mg monthly 1 g daily 15 g every other week 40 g monthly 40 mcg monthly 20 mg every other week 50 mg monthly 55 g monthly 60 g monthly 60 mg monthly 65 mg monthly 35 g every other week 90 g monthly 100 g monthly 60 g every other week 140 mg monthly 150 g monthly 150 mg monthly 156 g monthly 180 mg monthly 330 mcg monthly 442 mg monthly 500 mL monthly 550 mg monthly 800 mg monthly 1000 g monthly 2000 mg monthly 3900 mL monthly 400 mg daily 10000 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 3 Number of Patients: 3 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 3 Number of Patients: 3 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking IVIg Intravenous Immuno Globulin (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work
28 42% Did not seem to work: 42%
Course of treatment ended
25 37% Course of treatment ended: 37%
Doctor's advice
21 31% Doctor's advice: 31%
Other
8 12% Other: 12%
Side effects too severe
6 9% Side effects too severe: 9%
Expense
4 6% Expense: 6%

See all 66 patients who’ve stopped taking IVIg Intravenous Immuno Globulin

Currently Taking IVIg Intravenous Immuno Globulin

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
5
2
7
5
8

Stopped Taking IVIg Intravenous Immuno Globulin

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
18
12
9
11
5
11

Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Always
23 100%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
1 4%
Somewhat
8 35%
A little
9 39%
Not at all
5 22%

Cost

Paid out of pocket

$200+
3 13%
$100-199
0 0%
$50-99
0 0%
$25-49
2 9%
< $25
5 22%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 21, 2009.